HAND2-AS1 Inhibits Gastric Adenocarcinoma Cells Proliferation and Aerobic Glycolysis via miRNAs Sponge

Cancer Manag Res. 2020 May 1:12:3053-3068. doi: 10.2147/CMAR.S222878. eCollection 2020.

Abstract

Objective: To study the effect of lncRNA HAND2-AS1 on gastric adenocarcinoma (GA) cell property and explore its specific mechanism.

Methods: Data on stomach adenocarcinoma (STAD) were analyzed to screen differentially expressed lncRNA HAND2-AS1. RNA22-HAS database and dual luciferase reporter assay were applied to confirm the target relationship between HAND2-AS1/HIF3A and miR-184. The HAND2-AS1 and miR-184 expressions in tissue or cells were determined by qRT-PCR and Western blot. Besides, after GA cells (AGS) cultured in normoxic and hypoxic condition, phosphoenolpyruvate (PEP) and lactic acid were quantified by Phosphoenolpyruvate Fluorometric Assay Kit and Lactic Acid Detection kit, respectively. Additionally, colony formation assay, transwell invasion and migration assays were used to evaluate the abilities of cell invasion, migration, and proliferation in distinct conditions.

Results: The HAND2-AS1 and HIF3A expressions were down-regulated and miR-184 expression was up-regulated in GA tissues and cells. Dual luciferase reporter assay confirmed HAND2-AS1 and HIF3A were targeted by miR-184. AGS cell proliferation abilities were restrained by HAND2-AS1 and HIF3A overexpression and enhanced by miR-184, as well as migration and invasion abilities. In addition, HAND2-AS1 rescued enhanced AGS cell proliferation, cell migration, cell invasion abilities and glycolytic process caused by hypoxia via miR-184/HIF3A.

Conclusion: LncRNA HAND2-AS1 could inhibit GA cell proliferation, migration and invasion abilities and glycolytic process induced by hypoxia through miR-184/HIF3A signaling.

Keywords: cell proliferation; gastric adenocarcinoma; hypoxia; lactic acid; lncRNA.

Grants and funding

This study was supported by the Natural Science Foundation of Zhejiang Province (Grants no. LY18H290006), Zhejiang Provincial Medical and Healthy Science and Technology Projects (Grants No. WKJ-ZJ-1728, 2016KYB220), Program of Zhejiang Provincial TCM Sci-tech Plan (Grants no. 2016ZZ012, 2018ZY006, 2018ZB044), Zhejiang Provincial Science and Technology Projects (Grants no. 2018C37045), and National Natural Science Foundation of China (Grant No. 81573953, 81703753).